CNTN
Canton Strategic (CNTN)
NASDAQ
$2.11+$0.09 (+4.55%)
Price as of Aug 14, 2026 7:55 PM EDT
  • $155.8M
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-3.1M
-51.91%
-6.4M
+79.57%
-3.6M
+56.23%
-2.3M
+23.64%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
20.1M
+61.71%
12.4M
+31.50%
9.5M
+37.39%
6.9M
+114.52%
Operating Profit
-20.1M
+61.71%
-12.4M
+31.50%
-9.5M
+37.39%
-6.9M
+114.52%
Interest Income
41,410
-83.43%
249,908
+63.73%
152,631
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-16,505
-98.96%
-1.6M
+91.42%
Interest Income and Expense and Net
41,410
-83.43%
249,908
+83.59%
136,126
+108.55%
-1.6M
+91.42%
Total Nonoperating Income and Expense
-22.0M
-9,412.05%
236,224
+73.53%
136,126
+108.55%
-1.6M
-258.91%
Income before Taxes
-42.1M
+238.62%
-12.4M
+31.50%
-9.5M
+37.39%
-6.9M
+114.52%
Income Taxes
-6.2M
N/A
N/A
N/A
0
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-9.3M
+9.98%
-8.5M
+283.99%
Net Income from Continuing Operations Applicable to Common
-42.1M
N/A
N/A
N/A
-9.3M
+9.98%
-8.5M
+283.99%
Basic EPS and Net Income
-1.12
-88.10%
-9.41
+31.79%
-7.14
+852.00%
-0.75
+114.29%
Diluted EPS and Net Income
-1.12
-88.10%
-9.41
+31.79%
-7.14
+852.00%
-0.75
+114.29%
Basic Weighted Average Shares
32.0M
+2,372.39%
1.3M
-0.70%
1.3M
-88.46%
11.3M
+78.01%
Diluted Weighted Average Shares
32.0M
+2,372.39%
1.3M
-0.70%
1.3M
-88.46%
11.3M
+78.01%
Balance Sheet
Cash and Cash Equivalents
17.0M
+378.53%
3.6M
-67.45%
10.9M
+67.96%
6.5M
+149,361.29%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
17.0M
+378.53%
3.6M
-67.45%
10.9M
+67.96%
6.5M
+149,361.29%
Total Current Assets
17.4M
+367.16%
3.7M
-66.00%
10.9M
+63.66%
6.7M
+975.90%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
0
-100.00%
117,000
-78.61%
547,000
0.00%
547,000
+0.06%
Total Assets
519.1M
+13,849.46%
3.7M
-66.00%
10.9M
+63.66%
6.7M
+975.90%
Income Taxes Payable
117.9M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
200,000
-87.44%
Total Current Liabilities
3.3M
+36.14%
2.4M
+33.00%
1.8M
+58.52%
1.1M
-74.75%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
2.9M
+280.17%
Total Long-Term Liabilities
235.9M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
121.2M
+4,921.60%
2.4M
+33.00%
1.8M
+58.52%
1.1M
-78.42%
Retained Earnings
-72.8M
+97.33%
-36.9M
+49.38%
-24.7M
+60.57%
-15.4M
+122.60%
Total Stockholders Equity
397.9M
+30,330.80%
1.3M
-85.68%
9.1M
+64.72%
5.5M
+218.33%
Total Shares Outstanding
37.1M
+1,780.29%
2.0M
-83.19%
11.7M
+1.96%
11.5M
+81.12%
Cash Flow
Cash from Operating Activities
-16.1M
+47.94%
-10.9M
+49.34%
-7.3M
+11.32%
-6.6M
+503.73%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Cash from Investing Activities
-77.6M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
107.2M
+2,939.54%
3.5M
-69.93%
11.7M
-10.25%
13.1M
+1,353.59%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-105.69%
-54.41%
-231.81%
N/A
Return on Equity
N/A
N/A
N/A
N/A
-127.01%
-93.56%
-1,973.37%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.29
+243.15%
1.54
-74.44%
6.03
+3.24%
5.84
N/A
Cash Ratio
5.18
+251.50%
1.47
-75.53%
6.02
+5.95%
5.69
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
0.57
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
0.47
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow